Oliver A Zill (Oliver Zill)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 6

Top Venues

Nature communications

Journal for immunotherapy of cancer

Molecular cancer research : MCR

Nature biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Hem R Gurung, Amy J Heidersbach, Martine Darwish, Pamela Pui Fung Chan, Jenny Li, Maureen Beresini, Oliver A Zill, Andrew Wallace, Ann-Jay Tong, Dan Hascall, Eric Torres, Andy Chang, Kenny 'Hei-Wai' Lou, Yassan Abdolazimi, Christian Hammer, Ana Xavier-Magalhães, Ana Marcu, Samir Vaidya, Daniel D Le, Ilseyar Akhmetzyanova, Soyoung A Oh, Amanda J Moore, Uzodinma U Uche, Melanie B Laur, Richard J Notturno, Peter J R Ebert, Craig Blanchette, Benjamin Haley, Christopher M Rose
Systematic discovery of neoepitope-HLA pairs for neoantigens shared among patients and tumor types. Nature biotechnology (2023)
Andrew Wallace, Sima P Porten, Amy A Lo, Daniel Oreper, Nicolas Lounsbury, Charles Havnar, Ximo Pechuan-Jorge, Oliver A Zill, Maxwell V Meng
Origins and Timing of Emerging Lesions in Advanced Renal Cell Carcinoma. Molecular cancer research : MCR 20 (6) (2022)
Radia M Johnson, Xueping Qu, Chu-Fang Lin, Ling-Yuh Huw, Avinashnarayan Venkatanarayan, Ethan Sokol, Fang-Shu Ou, Nnamdi Ihuegbu, Oliver A Zill, Omar Kabbarah, Lisa Wang, Richard Bourgon, Felipe de Sousa E Melo, Chris Bolen, Anneleen Daemen, Alan P Venook, Federico Innocenti, Heinz-Josef Lenz, Carlos Bais
ARID1A mutations confer intrinsic and acquired resistance to cetuximab treatment in colorectal cancer. Nature communications 13 (1) (2022)
Amy A Lo, Andrew Wallace, Daniel Oreper, Nicolas Lounsbury, Charles Havnar, Ximo Pechuan-Jorge, Thomas D Wu, Richard Bourgon, Ryan Jones, Katrina Krogh, Guang-Yu Yang, Oliver A Zill
Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies. Journal for immunotherapy of cancer 9 (10) (2022)
Michael Fehlings, Leesun Kim, Xiangnan Guan, Kobe Yuen, Alireza Tafazzol, Shomyseh Sanjabi, Oliver A Zill, Deepali Rishipathak, Andrew Wallace, Alessandra Nardin, Siming Ma, Ana Milojkovic, Evan William Newell, Sanjeev Mariathasan, Mahesh Yadav
Single-cell analysis reveals clonally expanded tumor-associated CD57 + CD8 T cells are enriched in the periphery of patients with metastatic urothelial cancer responding to PD-L1 blockade. Journal for immunotherapy of cancer 10 (8) (2022)
Romain Banchereau, Ning Leng, Oliver A Zill, Ethan Sokol, Gengbo Liu, Dean Pavlick, Sophia Maund, Li-Fen Liu, Edward E Kadel, Nicole E Baldwin, Suchit Jhunjhunwala, Dorothee Nickles, Zoe June Assaf, Daniel Bower, Namrata Patil, Mark McCleland, David Shames, Luciana Molinero, Mahrukh A Huseni, Shomyseh Sanjabi, Craig Cummings, Ira Mellman, Sanjeev Mariathasan, Priti Hegde, Thomas Powles
Molecular determinants of response to PD-L1 blockade across tumor types. Nature communications 12 (1) (2021)

Oliver A Zill.css-eqlu8i{font-size:small;padding-left:4px;} (Oliver Zill)

Publication Activity (10 Years)

Top Topics

Top Venues

Oliver A Zill (Oliver Zill)